These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8120116)

  • 1. High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans.
    Lucas D; Berthou F; Girre C; Poitrenaud F; Ménez JF
    J Chromatogr; 1993 Dec; 622(1):79-86. PubMed ID: 8120116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of chlorzoxazone and its metabolite 6-hydroxychlorzoxazone in plasma by HPLC and their pharmacokinetics].
    Li L; Zhang Y
    Yao Xue Xue Bao; 1998 Oct; 33(10):731-6. PubMed ID: 12016924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.
    Frye RF; Stiff DD
    J Chromatogr B Biomed Appl; 1996 Nov; 686(2):291-6. PubMed ID: 8971612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing.
    Witt L; Suzuki Y; Hohmann N; Mikus G; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():207-13. PubMed ID: 27300008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive high-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma.
    Stiff DD; Frye RF; Branch RA
    J Chromatogr; 1993 Mar; 613(1):127-31. PubMed ID: 8458889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in the disposition of chlorzoxazone.
    de Vries JD; Salphati L; Horie S; Becker CE; Hoener BA
    Biopharm Drug Dispos; 1994 Oct; 15(7):587-97. PubMed ID: 7849234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of chlorzoxazone hydroxylase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid chromatographic method.
    Leclercq I; Horsmans Y; Desager JP
    J Chromatogr A; 1998 Dec; 828(1-2):291-6. PubMed ID: 9916314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and sensitive high-performance liquid chromatographic assay for 6-hydroxychlorzoxazone and chlorzoxazone in liver microsomes.
    Chittur SV; Tracy TS
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):479-83. PubMed ID: 9210455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase.
    Lucas D; Ménez C; Girre C; Bodénez P; Hispard E; Ménez JF
    Alcohol Clin Exp Res; 1995 Apr; 19(2):362-6. PubMed ID: 7625570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
    Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
    Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cytochrome P450 2E1 activity in microsomes by thin-layer chromatography using [2-14C]chlorzoxazone.
    Zerilli A; Lucas D; Berthou F; Bardou LG; Ménez JF
    J Chromatogr B Biomed Appl; 1996 Feb; 677(1):156-60. PubMed ID: 8925089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes.
    Draper AJ; Madan A; Latham J; Parkinson A
    Drug Metab Dispos; 1998 Apr; 26(4):305-12. PubMed ID: 9531516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes.
    Quesnot N; Bucher S; Gade C; Vlach M; Vene E; Valença S; Gicquel T; Holst H; Robin MA; Loyer P
    Arch Toxicol; 2018 Oct; 92(10):3077-3091. PubMed ID: 30151596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
    O'Shea D; Davis SN; Kim RB; Wilkinson GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.
    Burckart GJ; Frye RF; Kelly P; Branch RA; Jain A; Fung JJ; Starzl TE; Venkataramanan R
    Clin Pharmacol Ther; 1998 Mar; 63(3):296-302. PubMed ID: 9542473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.